Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans.

The Journal of infectious diseases - 1 Jun 2011

Orlinger Klaus K, Hofmeister Yvonne, Fritz Richard, Holzer Georg W, Falkner Falko G, Unger Bernd, Loew-Baselli Alexandra, Poellabauer Eva-Maria, Ehrlich Hartmut J, Barrett P Noel, Kreil Thomas R

Abstract excerpt

After vaccination of humans with tick-borne encephalitis virus (TBEV) vaccine, the extent of cross-neutralization between viruses of the European, Far Eastern, and Siberian subtypes of TBEV and Omsk hemorrhagic fever virus (OHFV) was analyzed. Hybrid viruses that encode the TBEV surface proteins for representative viruses within all subtypes, and OHFV, were constructed using the West Nile virus (WNV) backbone as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Neutralizing
Share to Cross Reactions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Encephalitis, Tick-Borne

Share to Encephalitis Viruses, Tick-Borne

Share to Neutralization Tests

Share to Viral Vaccines

Share to Virus Cultivation

Share to West Nile virus

Source

Identifiers

PMID: 21592984
DOI: 10.1093/infdis/jir122

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans.PMID 21592984Read ↗

Broadly neutralizing monoclonal antibodies protect against multiple tick-borne flaviviruses.Semantic proximity Read ↗

Demonstration of Cross-Protective Vaccine Immunity against an Emerging Pathogenic Ebolavirus SpeciesSemantic proximity Read ↗

A detailed mutagenesis study of flavivirus cross-reactive epitopes using West Nile virus-like particlesSemantic proximity Read ↗

Molecular epidemiology of tick-borne encephalitis virus: cross-protection between European and Far Eastern subtypesSemantic proximity Read ↗

Immunization with different recombinant West Nile virus envelope proteins induces varying levels of serological cross-reactivity and protection from infectionSemantic proximity Read ↗

T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus SpeciesSemantic proximity Read ↗

A Broadly Flavivirus Cross-Neutralizing Monoclonal Antibody that Recognizes a Novel Epitope within the Fusion Loop of E ProteinSemantic proximity Read ↗

Arthritogenic Alphavirus Vaccines: Serogrouping Versus Cross-Protection in Mouse ModelsSemantic proximity Read ↗

Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding Site.Semantic proximity Read ↗

Antigenic Variation of East/Central/South African and Asian Chikungunya Virus Genotypes in Neutralization by Immune Sera.Semantic proximity Read ↗

Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus GlycoproteinSemantic proximity Read ↗

West Nile virus: characterization and diagnostic applications of monoclonal antibodiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.